These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128 [TBL] [Abstract][Full Text] [Related]
6. B Cell Activating Factor (BAFF) in Long-term Kidney Transplant Recipients Is Not a Prognostic Marker for Allograft Dysfunction or Survival. Kościelska-Kasprzak K; Bartoszek D; Myszka M; Kamińska D; Boratyńska M; Krajewska M; Klinger M Transplant Proc; 2018; 50(6):1750-1754. PubMed ID: 30056894 [TBL] [Abstract][Full Text] [Related]
7. High Pretransplant BAFF Levels and B-cell Subset Polarized towards a Memory Phenotype as Predictive Biomarkers for Antibody-Mediated Rejection. Irure-Ventura J; San Segundo D; Rodrigo E; Merino D; Belmar-Vega L; Ruiz San Millán JC; Valero R; Benito A; López-Hoyos M Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991734 [TBL] [Abstract][Full Text] [Related]
8. Peripheral B-cell phenotype and BAFF levels are associated with HLA immunization in patients awaiting kidney transplantation. Snanoudj R; Candon S; Roelen DL; Jais JP; Claas FH; Legendre C; Chatenoud L Transplantation; 2014 May; 97(9):917-24. PubMed ID: 24827764 [TBL] [Abstract][Full Text] [Related]
10. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Pahl MV; Gollapudi S; Sepassi L; Gollapudi P; Elahimehr R; Vaziri ND Nephrol Dial Transplant; 2010 Jan; 25(1):205-12. PubMed ID: 19684120 [TBL] [Abstract][Full Text] [Related]
11. The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection. Xu H; He X; Sun J; Shi D; Zhu Y; Zhang X Transplant Proc; 2009; 41(1):112-6. PubMed ID: 19249491 [TBL] [Abstract][Full Text] [Related]
12. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay. Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014 [TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients. Min JW; Kim KW; Kim BM; Doh KC; Choi MS; Choi BS; Park CW; Yang CW; Kim YS; Oh EJ; Chung BH PLoS One; 2016; 11(9):e0162964. PubMed ID: 27631619 [TBL] [Abstract][Full Text] [Related]
14. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Lehnhardt AM; Strecker M; Eiermann T; Marget M; Thaiss F; Nashan B; Koch M Clin Transplant; 2015 Apr; 29(4):359-64. PubMed ID: 25627801 [TBL] [Abstract][Full Text] [Related]
15. Increased B cell activating factor is associated with B cell class switching in patients with tuberculous pleural effusion. Wang X; Liang KD; Zhang JA; Liu GB; Chen Z; Chen C; Zhuang ZG; Liu YQ; Luo HL; Li RX; Zheng BY; Xu JF Mol Med Rep; 2018 Aug; 18(2):1704-1709. PubMed ID: 29845274 [TBL] [Abstract][Full Text] [Related]